000			01938 a2200517 4500
005			20250516113929.0
264		0	_c20130702
008			201307s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mds292 _2doi
040			_aNLM _beng _cNLM
100	1		_aMattei, P L
245	0	0	_aCutaneous effects of BRAF inhibitor therapy: a case series. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cFeb 2013
300			_a530-537 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCarcinoma, Squamous Cell _xchemically induced
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aIndoles _xadverse effects
650	0	4	_aKeratoacanthoma _xchemically induced
650	0	4	_aKeratosis, Actinic _xchemically induced
650	0	4	_aMale
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOximes _xadverse effects
650	0	4	_aPhotosensitivity Disorders _xchemically induced
650	0	4	_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors
650	0	4	_aPyridones _xadverse effects
650	0	4	_aPyrimidinones _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aSkin Diseases _xchemically induced
650	0	4	_aSulfonamides _xadverse effects
650	0	4	_aVemurafenib
650	0	4	_aWarts _xchemically induced
700	1		_aAlora-Palli, M B
700	1		_aKraft, S
700	1		_aLawrence, D P
700	1		_aFlaherty, K T
700	1		_aKimball, A B
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 24 _gno. 2 _gp. 530-537
856	4	0	_uhttps://doi.org/10.1093/annonc/mds292 _zAvailable from publisher's website
999			_c22157141 _d22157141